![](https://endpts.com/wp-content/uploads/2022/09/peer_review_FI.jpg)
Philip Tagari switches Amgen's discovery lab for insitro's machine learning tools; CEO Joaquin Duato to chair J&J's board
In February, Philip Tagari will take a few days of retirement and then immediately return to industry. He won’t be leading the therapeutics discovery unit …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.